image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 12.39
-1.04 %
$ 1.13 B
Market Cap
-9.68
P/E
CASH FLOW STATEMENT
-111 M OPERATING CASH FLOW
-4.33%
31.9 M INVESTING CASH FLOW
141.16%
153 M FINANCING CASH FLOW
2011.25%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Myriad Genetics, Inc.
image
Net Income -263 M
Depreciation & Amortization 61.9 M
Capital Expenditures -73.3 M
Stock-Based Compensation 40.7 M
Change in Working Capital 27 M
Others 52.1 M
Free Cash Flow -184 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Jun-2020 Jun-2019 Jun-2018 Jun-2017 Jun-2016 Jun-2015 Jun-2014 Jun-2013 Jun-2012 Jun-2011 Jun-2010 Jun-2009 Jun-2008 Jun-2007 Jun-2006 Jun-2005 Jun-2004 Jun-2003 Jun-2002 Jun-2001 Jun-2000 Jun-1999 Jun-1998 Jun-1997 Jun-1996
OPERATING CASH FLOW
Net Income (263.3) (112.0) (27.2) (223.7) 4.6 4.6 131.0 21.8 125.3 80.2 176.2 147.1 112.2 100.7 152.3 84.6 47.8 (35.0) (38.2) (40.0) (40.6) (24.8) (14.0) (7.2) (8.7) (10.0) (9.8) (9.2) (5.9)
Depreciation & Amortization 61.9 52.7 62.8 71.4 73.0 73.0 54.4 48.3 26.7 25.0 13.8 8.9 9.1 7.2 7.1 9.4 8.8 7.5 6.9 6.1 5.8 5.3 4.5 3.7 3.3 3.2 3.3 2.5 1.6
Deferred Income Tax (0.6) (31.9) (34.7) (54.5) 13.1 13.1 (23.7) 2.5 15.7 1.7 7.5 8.2 34.2 40.4 (28.1) 0.5 0 0 0.2 0 0 0 0 0 0 0 0 0 0
Stock Based Compensation 40.7 38.1 36.3 24.3 33.5 33.5 27.1 29.9 31.6 45.7 27.1 26.6 26.3 25.1 22.8 25.7 0 0 (0.2) 0 0 0 0 0 0 0 0 0 0
Other Operating Activities 23.4 48.3 (139.4) 70.9 (3.4) (3.4) (51.3) 40.3 32.4 28.6 25.6 24.1 (11.1) (81.2) 28.4 17.9 30.3 12.7 4.7 4.5 2.0 0.4 0.5 0.4 0.5 0.2 100 K 0.2 100 K
Change in Working Capital 27.0 (101.5) 120.4 30.2 (37.1) (37.1) (21.6) (36.6) (65.4) (40.7) (60.0) (41.0) (28.8) 38.5 (27.4) (54.1) 16.9 (11.2) (1.4) 6.1 1.9 (27.3) (7.3) (0.7) 22.1 (7.5) (0.6) 100 K 5.6
Cash From Operations (110.9) (106.3) 18.2 (26.9) 83.7 83.7 115.9 106.2 166.3 140.5 190.2 173.9 141.8 130.8 155.1 84.0 103.7 (25.9) (28.0) (23.3) (30.9) (46.5) (16.3) (3.8) 17.2 (14.1) (7.0) (6.6) 1.4
INVESTING CASH FLOW
Capital Expenditures (73.3) (45.3) (18.0) (13.2) (8.6) (8.6) (8.4) (6.1) (5.0) (23.9) (14.3) (11.4) (10.2) (5.8) 0 (7.5) (13.7) (11.4) (7.7) (6.7) (3.9) (8.0) (6.9) (5.3) (4.6) (4.0) (3.2) (4.7) (6.4)
Other Items 105.2 (32.2) 292.4 74.8 (277.8) (277.8) (3.2) (140.2) (86.4) 64.8 (3.4) (64.2) (28.7) (48.6) (76.7) (198.8) (17.6) (35.3) (65.1) 26.3 5.8 (3.9) 44.9 (79.8) 0.3 8.5 0.5 9.4 (52.6)
Cash From Investing Activities 31.9 (77.5) 274.4 61.6 (286.4) (286.4) (11.6) (146.3) (91.4) 40.9 (17.7) (75.6) (38.9) (54.4) (76.7) (206.3) (31.3) (46.7) (72.8) 19.5 1.9 (12.0) 38.1 (85.1) (4.3) 4.5 (2.7) 4.7 (59.0)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 (3.9) (50.0) (50.0) 0 (31.6) (162.6) (210.7) (287.7) (146.3) (128.5) (200.5) (71.4) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 39.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 (340.0) (340.0) 0 (403.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (4.5) (14.3) (16.0) 11.5 678.6 338.6 11.1 805.4 94.3 3.4 75.9 65.7 59.2 58.8 0 (136.1) 0 0 0 0 0 0 0 0 0 (0.2) (0.4) (0.3) (0.3)
Cash From Financing Activities 152.9 (8.0) (150.6) (1.0) 182.3 182.3 (95.0) 71.8 (68.3) (177.3) (211.8) (80.6) (69.2) (116.6) (49.1) (51.9) 21.9 117.5 149.9 2.5 51.3 59.0 3.4 68.6 38.0 0.4 0.2 4.3 58.9
CHANGE IN CASH
Net Change In Cash 74.5 (192.4) 141.4 70.5 (17.7) (17.7) 8.5 33.9 4.4 (0.7) (39.3) 17.7 33.7 (40.2) 29.3 (174.2) 94.3 44.9 49.1 (1.3) 22.4 0.5 25.1 (20.3) 50.8 (9.2) (24.1) (13.2) (11.9)
FREE CASH FLOW
Free Cash Flow (184.2) (151.6) 0.2 (40.1) 75.1 75.1 107.5 100.1 161.3 116.6 175.9 162.5 131.7 125.0 155.1 76.5 90.1 (37.3) (35.7) (30.0) (34.8) (54.6) (23.2) (9.0) 12.5 (18.1) (10.2) (11.3) (5.0)